PRO-DEX, INC. Form PRE 14A: Preliminary proxy statement
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2009-10-06: Form PRE 14A; Period of report 2009-12-04; Description Preliminary proxy statement; Document espdex2009.htm.
- 2008-10-31: Form PRE 14A; Period of report 2009-01-09; Description Preliminary proxy statement; Document espdexproxy1.htm.
- 2007-10-12: Form PRE 14A; Period of report 2007-12-04; Description Preliminary proxy statement; Document espdexproxy1.htm.
- 2003-10-17: Form PRE 14A; Period of report 2003-12-11; Description Preliminary proxy statement; Document pdex14a1.htm.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2009-10-06 | PRE 14A | 2009-12-04 | Preliminary proxy statement | espdex2009.htm |
| 2008-10-31 | PRE 14A | 2009-01-09 | Preliminary proxy statement | espdexproxy1.htm |
| 2007-10-12 | PRE 14A | 2007-12-04 | Preliminary proxy statement | espdexproxy1.htm |
| 2003-10-17 | PRE 14A | 2003-12-11 | Preliminary proxy statement | pdex14a1.htm |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |